Literature DB >> 8847210

Alterations in levels of different protein kinase C isotypes and their influence on behavior of squamous cell carcinoma of the oral cavity: epsilon PKC, a novel prognostic factor for relapse and survival.

C Martínez-Gimeno1, M T Díaz-Meco, I Domínguez, J Moscat.   

Abstract

BACKGROUND: Recent results suggest that some PKC isotypes, when overexposed, confer to cultured fibroblasts certain proliferative advantages, and enhanced tumorigenicity in nude mice, suggesting their participation in carcinogenic process. These findings need to be validated through the investigation of potential alterations of these kinases in common forms of human cancers.
MATERIAL AND METHODS: In this prospective study we determined levels of different PKC isozymes by Western blot in tissue extracts from 29 human primary squamous cell carcinomas of the oral cavity, and their respective controls. These expressions were correlated with behavior of tumor and histologic characteristics.
RESULTS: Dramatic alterations in different PKC isotypes were found. Thus, increased levels of isotypes alpha, beta, or gamma, and zeta were found in most of the patients, as well as significant correlations between levels of the isotype epsilon and survival-relapse rate and classical PKC isotypes with irregular morphology of tumoral interphase.
CONCLUSIONS: These results suggest participation of some PKC isotypes (alpha, beta, gamma, and zeta) in the genesis and behavior (epsilon) of oral cancers. Levels of epsilon PKC could be used as prognostic marker.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8847210     DOI: 10.1002/hed.2880170609

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  17 in total

Review 1.  Molecular parameters of head and neck cancer metastasis.

Authors:  Sanjay L Bhave; Theodoras N Teknos; Quintin Pan
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

2.  Preclinical development of a bifunctional cancer cell homing, PKCepsilon inhibitory peptide for the treatment of head and neck cancer.

Authors:  Liwei Bao; Michael A Gorin; Manchao Zhang; Alejandra C Ventura; William C Pomerantz; Sofia D Merajver; Theodoros N Teknos; Anna K Mapp; Quintin Pan
Journal:  Cancer Res       Date:  2009-06-30       Impact factor: 12.701

3.  Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma.

Authors:  Quintin Pan; Li Wei Bao; Theodoros N Teknos; Sofia D Merajver
Journal:  Cancer Res       Date:  2006-10-01       Impact factor: 12.701

4.  Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCε, Stat3, and Epithelial-to-Mesenchymal Transition Markers.

Authors:  Bilal Bin Hafeez; Joseph W Fischer; Ashok Singh; Weixiong Zhong; Ala Mustafa; Louise Meske; Mohammad Ozair Sheikhani; Ajit Kumar Verma
Journal:  Cancer Prev Res (Phila)       Date:  2015-01-27

5.  Protein Kinase C Epsilon Is a Key Regulator of Mitochondrial Redox Homeostasis in Acute Myeloid Leukemia.

Authors:  Daniela Di Marcantonio; Esteban Martinez; Simone Sidoli; Jessica Vadaketh; Margaret Nieborowska-Skorska; Anushk Gupta; Jake M Meadows; Francesca Ferraro; Elena Masselli; Grant A Challen; Michael D Milsom; Claudia Scholl; Stefan Fröhling; Siddharth Balachandran; Tomasz Skorski; Benjamin A Garcia; Prisco Mirandola; Giuliana Gobbi; Ramiro Garzon; Marco Vitale; Stephen M Sykes
Journal:  Clin Cancer Res       Date:  2017-11-10       Impact factor: 12.531

6.  Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model.

Authors:  Bilal Bin Hafeez; Weixiong Zhong; Joseph W Fischer; Ala Mustafa; Xudong Shi; Louise Meske; Hao Hong; Weibo Cai; Thomas Havighurst; Kyungmann Kim; Ajit K Verma
Journal:  Mol Oncol       Date:  2012-12-14       Impact factor: 6.603

7.  Plumbagin inhibits prostate cancer development in TRAMP mice via targeting PKCε, Stat3 and neuroendocrine markers.

Authors:  Bilal Bin Hafeez; Weixiong Zhong; Ala Mustafa; Joseph W Fischer; Olya Witkowsky; Ajit K Verma
Journal:  Carcinogenesis       Date:  2012-09-13       Impact factor: 4.944

8.  Serum levels of FAK and some of its effectors in adult AML: correlation with prognostic factors and survival.

Authors:  Mona G El-Sisi; Sara M Radwan; Alia M Saeed; Hala O El-Mesallamy
Journal:  Mol Cell Biochem       Date:  2021-01-28       Impact factor: 3.396

9.  Expression of protein kinase C family in human hepatocellular carcinoma.

Authors:  Hsiu-Chin Lu; Fen-Pi Chou; Kun-Tu Yeh; Ya-Sian Chang; Nicholas C Hsu; Jan-Gowth Chang
Journal:  Pathol Oncol Res       Date:  2009-12-01       Impact factor: 3.201

10.  Transcriptional regulation of oncogenic protein kinase Cϵ (PKCϵ) by STAT1 and Sp1 proteins.

Authors:  HongBin Wang; Alvaro Gutierrez-Uzquiza; Rachana Garg; Laura Barrio-Real; Mahlet B Abera; Cynthia Lopez-Haber; Cinthia Rosemblit; Huaisheng Lu; Martin Abba; Marcelo G Kazanietz
Journal:  J Biol Chem       Date:  2014-05-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.